APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 90 filers reported holding APPLIED GENETIC TECHNOL CORP in Q1 2017. The put-call ratio across all filers is 263.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $401,000 | -73.7% | 1,477,636 | -25.4% | 0.00% | – |
Q2 2022 | $1,526,000 | -28.0% | 1,981,565 | 0.0% | 0.00% | – |
Q1 2022 | $2,120,000 | -35.6% | 1,981,565 | +14.4% | 0.00% | – |
Q4 2021 | $3,293,000 | -37.0% | 1,732,746 | -0.2% | 0.00% | – |
Q3 2021 | $5,223,000 | -23.0% | 1,735,372 | 0.0% | 0.00% | – |
Q2 2021 | $6,785,000 | -28.5% | 1,735,372 | -7.3% | 0.00% | – |
Q1 2021 | $9,490,000 | +138.9% | 1,871,809 | +92.7% | 0.00% | – |
Q4 2020 | $3,973,000 | -13.1% | 971,280 | +3.3% | 0.00% | – |
Q3 2020 | $4,572,000 | -13.3% | 940,704 | -1.1% | 0.00% | – |
Q2 2020 | $5,271,000 | +81.3% | 951,395 | +7.4% | 0.00% | – |
Q1 2020 | $2,907,000 | -5.8% | 886,163 | +29.8% | 0.00% | – |
Q4 2019 | $3,086,000 | +8.6% | 682,728 | 0.0% | 0.00% | – |
Q3 2019 | $2,841,000 | +25.3% | 682,728 | +14.1% | 0.00% | – |
Q2 2019 | $2,267,000 | -9.9% | 598,330 | -0.3% | 0.00% | – |
Q1 2019 | $2,515,000 | +81.5% | 600,231 | +7.8% | 0.00% | – |
Q4 2018 | $1,386,000 | -61.6% | 556,836 | +12.6% | 0.00% | – |
Q3 2018 | $3,611,000 | +99.5% | 494,618 | +1.1% | 0.00% | – |
Q2 2018 | $1,810,000 | +5.6% | 489,318 | +9.9% | 0.00% | – |
Q1 2018 | $1,714,000 | +5.2% | 445,245 | -1.6% | 0.00% | – |
Q4 2017 | $1,630,000 | -14.9% | 452,675 | -6.7% | 0.00% | – |
Q3 2017 | $1,916,000 | -24.4% | 485,176 | -2.3% | 0.00% | – |
Q2 2017 | $2,533,000 | -31.9% | 496,647 | -7.9% | 0.00% | – |
Q1 2017 | $3,722,000 | -25.7% | 539,349 | +0.7% | 0.00% | – |
Q4 2016 | $5,007,000 | +3.3% | 535,458 | +8.1% | 0.00% | – |
Q3 2016 | $4,847,000 | -23.1% | 495,564 | +11.1% | 0.00% | – |
Q2 2016 | $6,302,000 | +8.8% | 445,962 | +7.7% | 0.00% | – |
Q1 2016 | $5,790,000 | -20.5% | 414,200 | +16.0% | 0.00% | – |
Q4 2015 | $7,283,000 | -96.1% | 357,017 | -93.1% | 0.00% | -100.0% |
Q3 2015 | $187,641,000 | +5320.0% | 5,172,560 | +2192.1% | 0.01% | – |
Q2 2015 | $3,462,000 | -10.4% | 225,672 | +16.7% | 0.00% | – |
Q1 2015 | $3,864,000 | +21.5% | 193,329 | +27.8% | 0.00% | – |
Q4 2014 | $3,181,000 | +20.1% | 151,318 | +6.3% | 0.00% | – |
Q3 2014 | $2,649,000 | +90.2% | 142,343 | +136.0% | 0.00% | – |
Q2 2014 | $1,393,000 | – | 60,312 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 167,192 | $2,362,000 | 1.87% |
Perceptive Advisors | 658,851 | $9,309,000 | 0.64% |
Iguana Healthcare Management, LLC | 100,000 | $1,413,000 | 0.58% |
EMERALD MUTUAL FUND ADVISERS TRUST | 416,498 | $5,885,000 | 0.33% |
TFS CAPITAL LLC | 111,937 | $1,582,000 | 0.29% |
GLOBEFLEX CAPITAL L P | 70,554 | $997,000 | 0.27% |
Eventide Asset Management | 279,100 | $3,944,000 | 0.24% |
EMERALD ADVISERS, LLC | 290,784 | $4,109,000 | 0.20% |
Spark Investment Management LLC | 133,600 | $1,887,000 | 0.18% |
Virtus ETF Advisers LLC | 16,223 | $229,000 | 0.17% |